Delivery Order SPE2DB22D1017-SPE2DB25FG0HA
Award Date
4/16/25
Potential Completion Date
4/17/25
Potential Value
$28K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB20D1047|SPE2DB25FF54R, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,894.80 firm-fixed-price delivery order is for the supply of Descovy 200-25 mg tablets, a prescription medication. The contract has an ultimate completion date of April 17, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award, with an ID of SPE2DB24D2010|SPE2DB25FZYF7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $22,330.13 firm fixed-price delivery order is for the supply of Descovy 200-25 mg tablets, with a period of performance through May 2, 2025. The award is not set-aside and represents part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,992.55 firm fixed-price delivery order is for the supply of Descovy 200-25 mg tablets. The contract has an ultimate completion date of May 14, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,318.41 delivery order contract is for the provision of the prescription medication Descovy 200-25 mg tablet, with a performance period ending on May 9, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award is a delivery order (SPE2DB25FBEDD) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,894.80, is for the delivery of Descovy 200-25 mg tablet medication. The award is a firm fixed-price contract with a completion date of May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,586.04 firm fixed-price delivery order is for the medication Descovy 200-25 mg Tablet, a pharmaceutical product used in the treatment of various medical conditions. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was...
This federal contract award, with ID SPE2DB25D3404|SPE2DB25FUMYY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,933.47 firm fixed-price delivery order is for the supply of Descovy 200-25 mg tablets, a pharmaceutical product. The contract has an ultimate completion date of April 16, 2025 and does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $12,735.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Descovy 200-25 mg tablet medication. The contract is a Firm Fixed Price Delivery Order, with a performance period extending through May 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. This award is not designated as a set-aside contract, suggesting...
This federal contract award, valued at $47,229.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Descovy 200-25 mg tablets, a prescription medication. It is a firm-fixed-price contract without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,750.99 firm fixed-price delivery order is for the medication Descovy 200-25 mg tablet, with a completion date of January 27, 2025. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...